Chinese fintech giant Ant upgrades AI health app to tap booming eldercare, wellness demand


Chinese fintech giant Ant Group has pressed ahead with its strategic move into the fast-growing healthcare sector with a major upgrade to its artificial intelligence health app AQ, positioning the platform to work like a fitness companion or a family doctor.

The new features included integration of records from smart devices made by Apple, Huawei and Omron, among others, as well as the creation of health profiles for family members, the company announced on Monday. Ant is the fintech affiliate of Alibaba Group Holding, owner of the Post.

AQ also introduced tools such as health goal setting and smart reminders, enabling it to function like a personal trainer that could “create tailored plans and send daily reminders to help users stay on track”.

With the new “companion” features, the existing question-and-answer function would become “more accurate and personalised” as it had a more comprehensive view of a user’s well-being, Ant said. The Q&A channel, handling both text and image consultations, now answered more than 5 million questions every day, it added.

It is estimated that by around 2035, the population aged 60 and above in mainland China will exceed 400 million. Photo: Xinhua
It is estimated that by around 2035, the population aged 60 and above in mainland China will exceed 400 million. Photo: Xinhua

The company said AQ was not intended to provide medical diagnoses or replace professional doctors. The platform was designed to “help users address common, everyday health questions and support healthy habit formation”, said Zhang Junjie, vice-president for health business at Ant.

  • Related Posts

    JD.com posts first quarterly loss in nearly four years as delivery battle takes toll

    Chinese e-commerce giant JD.com reported a 2.7 billion yuan (US$392 million) loss in the fourth quarter and a halving of annual profit amid an ongoing food delivery battle it ignited…

    Continue reading
    China and Hong Kong should relax biotech listing rules, venture capitalist says

    Mainland China and Hong Kong should ease listing rules for biotechnology companies and lower takeover thresholds for listed firms to capitalise on renewed foreign interest in the healthcare sector, venture…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *